Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Nicole MurphyHead of Pharm Ops and Tech | BiogenBIIB | Open-market buy | 02/12 | 02/17 | 3 sh | $195.04 | $585.12 | +0.0% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 02/09 | 02/10 | 2,660 sh | $199.83 | $531,547.8 | −24.9% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 02/02 | 02/03 | 748 sh | $179.30 | $134,116.4 | −10.7% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 25/09/02 | 25/09/02 | 517 sh | $133.55 | $69,045.35 | −8.2% |
Rachid IzzarHead of Global Product Strat | BiogenBIIB | Open-market sale10b5-1 plan | 25/07/08 | 25/07/16 | 2,223 sh | $135.00 | $300,105 | −26.0% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 25/05/19 | 25/05/20 | 3,806 sh | $126.25 | $480,507.5 | −41.2% |
Caroline DorsaDirector | BiogenBIIB | Open-market buy | 25/05/02 | 25/05/05 | 1,235 sh | $122.72 | $151,559.2 | +4.6% |
Stephen A. SherwinDirector | BiogenBIIB | Open-market sale10b5-1 plan | 25/03/07 | 25/03/10 | 8,760 sh | $150.02 | $1,314,175.2 | −43.6% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 24/12/09 | 24/12/09 | 110 sh | $157.21 | $17,293.1 | −2.0% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 24/09/03 | 24/09/05 | 431 sh | $204.22 | $88,018.82 | −7.5% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 24/04/02 | 24/04/03 | 93 sh | $213.09 | $19,817.37 | −1.9% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 24/02/22 | 24/02/26 | 262 sh | $221.23 | $57,962.26 | −5.1% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 24/02/16 | 24/02/21 | 108 sh | $221.49 | $23,920.92 | −2.1% |
Eric K. RowinskyDirector | BiogenBIIB | Open-market buy | 24/02/15 | 24/02/20 | 455 sh | $222.54 | $101,255.7 | +2.3% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 24/02/12 | 24/02/13 | 419 sh | $239.45 | $100,329.55 | −8.5% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 24/02/02 | 24/02/05 | 634 sh | $245.93 | $155,919.62 | −13.4% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 23/12/11 | 23/12/12 | 110 sh | $248.00 | $27,280 | −3.1% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 23/09/05 | 23/09/06 | 431 sh | $269.43 | $116,124.33 | −11.4% |
Priya SinghalHead of Development | BiogenBIIB | Open-market sale10b5-1 plan | 23/07/03 | 23/07/05 | 81 sh | $282.87 | $22,912.47 | −2.7% |
Ginger GregoryEVP, Human Resources | BiogenBIIB | Open-market sale10b5-1 plan | 23/04/28 | 23/05/02 | 2,681 sh | $300.00 | $804,300 | −24.0% |